SNCA and Parkinson disease: Globally, due to the negative results of different anti-α-synuclein trials, a debate is ongoing as to whether toxic α-synuclein aggregation is the real culprit or rather if it is a loss of function in PD (gain-of-function vs. loss-of-function theories).